DOCSLIB.ORG

Dietary Chalcones with Chemopreventive and Chemotherapeutic Potential

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Dietary Chalcones with Chemopreventive and Chemotherapeutic Potential Genes Nutr (2011) 6:125–147 DOI 10.1007/s12263-011-0210-5 RESEARCH PAPER Dietary chalcones with chemopreventive and chemotherapeutic potential Barbora Orlikova • Deniz Tasdemir • Frantisek Golais • Mario Dicato • Marc Diederich Received: 23 July 2010 / Accepted: 6 January 2011 / Published online: 4 February 2011 Ó Springer-Verlag 2011 Abstract Chalcones are absorbed in the daily diet and Introduction appear to be promising cancer chemopreventive agents. Chalcones represent an important group of the polyphenolic Polyphenols represent one of the most prevalent classes of family, which includes a large number of naturally occurring compounds found in our daily diet [171]. Over the last ten molecules. This family possesses an interesting spectrum of years, increasing attention has been dedicated to chalcones biological activities, including antioxidative, antibacterial, because of their interesting biological activities. Indeed, anti-inflammatory, anticancer, cytotoxic, and immuno- chalcones constitute an important group of natural com- suppressive potential. Compounds of this family have been pounds that are especially abundant in fruits (e.g., citruses, shown to interfere with each step of carcinogenesis, apples), vegetables (e.g., tomatoes, shallots, bean sprouts, including initiation, promotion and progression. Moreover, potatoes) and various plants and spices (e.g., licorice),— numerous compounds from the family of dietary chalcones many of which have been used for centuries in traditional appear to show activity against cancer cells, suggesting that herbal medicine [29]. Chemically, chalcones are open- these molecules or their derivatives may be considered as chain flavonoids bearing two aromatic rings linked by a potential anticancer drugs. This review will focus primarily three-carbon enone moiety (Fig. 1). The majority of the on prominent members of the chalcone family with an content of chalcones in citrus fruits and various plants is 1,3-diphenyl-2-propenon core structure. Specifically, the mediated through the formation of 4,20,40,60-tetrahydroxy- inhibitory effects of these compounds on the different steps chalcone (also known as naringenin chalcone (1))by of carcinogenesis that reveal interesting chemopreventive chalcone synthase (Fig. 2)[77]. Naringenin chalcone (1) and chemotherapeutic potential will be discussed. also plays an essential role in the flavonoid biosynthetic pathway and contributes significantly to the total amount of Keywords Diet Á Chalcone derivatives Á plant flavonoids [35]. Although chalcones occur naturally, Chemoprevention Á Chemotherapy they could be available in larger amounts through an effi- cient and simple synthesis. Briefly, synthesis through base- catalyzed Claisen–Schmidt condensation of an aromatic & B. Orlikova Á M. Dicato Á M. Diederich ( ) aldehyde and an appropriate ketone in a polar solvent Laboratoire de Biologie Mole´culaire et Cellulaire du Cancer, Fondation de Recherche Cancer et Sang, Hoˆpital Kirchberg, (methanol or ethanol) renders them a readily available 9 Rue Edward Steichen, 2540 Luxembourg, Luxembourg nutrition component/supplement in either natural or syn- e-mail: [email protected] thesized form [147] (Fig. 3). The present paper is primarily concerned with chalcone D. Tasdemir Department of Pharmaceutical and Biological Chemistry, derivatives found in edible plants, fruits, and vegetables The School of Pharmacy, University of London, and with their positive effects in cancer chemoprevention 29-39 Brunswick Square, London WC1N 1AX, UK and carcinogenesis. Cancer chemoprevention can target each step of carcinogenesis with natural or synthetic sub- F. Golais Department of Microbiology and Virology, Faculty of Sciences, stances [160]. Because of unsatisfactory cancer treatment Comenius University, Bratislava, Slovakia options and adverse side effects caused by currently used 123 126 Genes Nutr (2011) 6:125–147 Polyphenols Inflammation cell-signaling pathways targeted by chalcones Phenolic acidsFlavonoids Stilbenes Lignans The tight interplay between chronic inflammation and cancer was first established and carefully documented by Virchow Chalcones Isoflavonoids in 1863 when he observed leukocytes in neoplastic tissues. Flavonols Anthocyanidins Since then, many scientists have provided evidence under- Flavones Flavanones lining the strong dependency between these two processes. 3 Natural compounds, including chalcones, have been shown 2 4 B 1 5 6 to interact with, abrogate, and abolish inflammatory signal- 3' α 4' 2' A 5' 1' β ing (see Fig. 4). Moreover, a single compound can target 6' multiple signaling events and contribute to inhibition of the O synthesis of inflammatory mediators. Fig. 1 Schematic representation of main polyphenol family mem- Nuclear factor (NF)-jB is a mediator of inflammatory bers. Polyphenols are subdivided into 4 main classes—phenolic acids, diseases and cancer and has been shown to induce resistance to flavonoids, stilbenes, and lignans—according to the number of phenol various chemotherapeutic agents. This transcription factor is rings they include and the structural elements that bind these rings together [114]. Flavonoids can be further divided into various implicated in immunity, anti-apoptosis, proliferation, and subclasses of which chalcones, flavonols, flavones, flavanones, activation of more than 550 target genes involved in tumor anthocyanidins, and isoflavonoids are the most common. The core promotion, angiogenesis, and metastasis. The canonical NF- 1,3-diphenyl-2-propenon chalcone structure is shown jB pathway is characterized by a cascade leading to activation of the functional heterodimer p50/p65. After stimulation by chemotherapeutic compounds, great emphasis has been put tumor necrosis factor (TNF)a, activation of the Ij kinase on the use of non-toxic dietary substances and botanical (IKK) complex leads to phosphorylation of the inhibitory products, either alone or in a co-treatment. subunit IjBa followed by subsequent proteasomal degrada- Various chalcones completely inhibit different steps of tion. As a result, NF-jB p50/p65 translocates to the nucleus carcinogenesis from the very early stages, including tumor and transcription is activated. initiation, through promotion, progression, angiogenesis, Besides NF-jB signaling, other pathways are strongly and invasion, to the very late stages leading to metastasis. linked to inflammation processes, including extracellular They are also strongly implicated in the negative regulation signal-regulated kinase (ERK), c-Jun N-terminal kinases of cell cycle progression and favor cell death mechanisms, (JNK), and p38 signal transduction pathways. The ERK1/ predominantly apoptosis, in transformed cells. Moderation 2-mediated signaling pathway is activated by growth fac- of these processes is generally associated with the involve- tors, cytokines, carcinogens, or viral proteins. Initially, this ment of chalcones in an elaborate network of inflammatory pathway was thought to be limited exclusively to cell cell-signaling pathways that largely contribute to tumor growth and proliferation, but there is growing evidence promotion. indicating its involvement in several inflammatory pro- This review will focus on members of the chalcone class cesses [136]. The family of JNK enzymes is implicated in with the 1,3-diphenyl-2-propenon core structure and the cell proliferation, survival, and apoptosis through the inhibitory effect of these compounds on the different steps activation of stress and inflammation. Inhibition of JNK- of carcinogenesis that highlight their interesting chemo- mediated AP-1 activation is a promising approach for preventive and chemotherapeutic potential. inhibition of the inducible expression of inflammatory CO-S-CoA OH HO OH OO + CoA HO S Chalcone synthase OH O OH 4-Coumaroyl- CoA (3x) Malonyl-CoA Naringenin chalcone Fig. 2 Biosynthesis of naringenin chalcone in plants and citruses. resulting in the formation of naringenin chalcone, which acts as a The condensation of three molecules of malonyl-CoA and one substrate for further synthesis of flavonoids molecule of 4-coumaroyl-CoA is catalyzed by chalcone synthetase 123 Genes Nutr (2011) 6:125–147 127 OH OH O HO OH HO OH O OH O OH O O 1 naringenin chalcone 2 isoliquiritigenin 3 1,2-dihydroparatocarpin A OH HO OH OH H O O OH OH O OH HO OH HO H HO O OH HO O O OH O OH O 4 isoliquiritin apioside 5 xanthohumol 6 broussochalcone A OH OH H3CO OH HO OH HO OH OH O O-Glc O OH O 7 phloretin 8 phloridzin 9 myrigalone B OH O OCH3 OH HO OH O O O 10 chalcone 11 2-hydroxychalcone 12 xanthohumol B OH OH OH HO OCH3 HO OCH3 HO OH OH O OH O OH O 13 xanthohumol D 14 dihydroxanthohumol 15 isobavachalcone CH3 OH OH CH3 OH HO HO OH OCH3 O O OH O 16 butein 17 4-hydroxychalcone 18 licochalcone A Fig. 3 Chemical structures of naturally occurring chalcone derivatives genes in cancer and other pathologies [115]. The p38 mitogen- Finally, the crosstalk of these pathways with NF-jB cell activated protein kinase (MAPK) pathway is critical for the signaling contributes to induction of key inflammatory synthesis and activity of multiple pro-inflammatory cytokines enzymes such as cyclooxygenase (COX)-2 and inducible (TNF-a, interleukin (IL)-1, IL-6, IL-8). nitric oxide synthase (iNOS) [27]. 123 128 Genes Nutr (2011) 6:125–147 OH OH OH HO HO HO OH OH OH OCH3 OCH3 OH O O OCH3 O 19 7,9,2´,4´-tetrahydroxy-8-isopentenyl-5-methoxychalcone 20 licochalcone B 21 licochalcone D HO OH H3CO OCH3 OCH3 HO O HO OCH3 OH OH HO HO OH OH O OH O O HO OH O O HO HO 22 cardamonin 23 flavokawain A 24 hydroxysafflor yellow A OH OH OH OH HO O OH OH H3CO OH O HO OH O OH HO O O OH HO OH O OH OH O 25 isobutrin 26 desmethylxanthohumol 27 asebogenin O-Glc OH HO HO OH HO OCH3 O O OH O 28 isoliquiritigenin 2´-methyl ether 29 2´,4´-dihydroxychalcone 30 isoliquiritin OH HO OCH3 H3CO OH HO OH O OH O O 31 ON-III 32 2´-hydroxy-4´-methoxychalcone 33 xanthoangelol OH OCH HO 3 H3CO OH OH OCH HO 3 OH O OH O OH O 34 4-hydroxyderricin 35 uvaretin 36 isouvaretin Fig. 3 continued It has been reported that chalcone (10) provided two abrogated time and dose dependently the activation of distinct cytoprotective mechanisms, depending on the signal transducer and activator of transcription (STAT)3 duration of pre-treatment.
Load more

Recommended publications
  • (12) United States Patent (10) Patent No.: US 9.421,180 B2 Zielinski Et Al
    USOO9421 180B2 (12) United States Patent (10) Patent No.: US 9.421,180 B2 Zielinski et al. (45) Date of Patent: Aug. 23, 2016 (54) ANTIOXIDANT COMPOSITIONS FOR 6,203,817 B1 3/2001 Cormier et al. .............. 424/464 TREATMENT OF INFLAMMATION OR 6,323,232 B1 1 1/2001 Keet al. ............ ... 514,408 6,521,668 B2 2/2003 Anderson et al. ..... 514f679 OXIDATIVE DAMAGE 6,572,882 B1 6/2003 Vercauteren et al. ........ 424/451 6,805,873 B2 10/2004 Gaudout et al. ....... ... 424/401 (71) Applicant: Perio Sciences, LLC, Dallas, TX (US) 7,041,322 B2 5/2006 Gaudout et al. .............. 424/765 7,179,841 B2 2/2007 Zielinski et al. .. ... 514,474 (72) Inventors: Jan Zielinski, Vista, CA (US); Thomas 2003/0069302 A1 4/2003 Zielinski ........ ... 514,452 Russell Moon, Dallas, TX (US); 2004/0037860 A1 2/2004 Maillon ...... ... 424/401 Edward P. Allen, Dallas, TX (US) 2004/0091589 A1 5, 2004 Roy et al. ... 426,265 s s 2004/0224004 A1 1 1/2004 Zielinski ..... ... 424/442 2005/0032882 A1 2/2005 Chen ............................. 514,456 (73) Assignee: Perio Sciences, LLC, Dallas, TX (US) 2005, 0137205 A1 6, 2005 Van Breen ..... 514,252.12 2005. O154054 A1 7/2005 Zielinski et al. ............. 514,474 (*) Notice: Subject to any disclaimer, the term of this 2005/0271692 Al 12/2005 Gervasio-Nugent patent is extended or adjusted under 35 et al. ............................. 424/401 2006/0173065 A1 8/2006 BeZwada ...................... 514,419 U.S.C. 154(b) by 19 days. 2006/O193790 A1 8/2006 Doyle et al.
    [Show full text]
  • Herbal Insomnia Medications That Target Gabaergic Systems: a Review of the Psychopharmacological Evidence
    Send Orders for Reprints to [email protected] Current Neuropharmacology, 2014, 12, 000-000 1 Herbal Insomnia Medications that Target GABAergic Systems: A Review of the Psychopharmacological Evidence Yuan Shia, Jing-Wen Donga, Jiang-He Zhaob, Li-Na Tanga and Jian-Jun Zhanga,* aState Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P.R. China; bDepartment of Pharmacology, School of Marine, Shandong University, Weihai, P.R. China Abstract: Insomnia is a common sleep disorder which is prevalent in women and the elderly. Current insomnia drugs mainly target the -aminobutyric acid (GABA) receptor, melatonin receptor, histamine receptor, orexin, and serotonin receptor. GABAA receptor modulators are ordinarily used to manage insomnia, but they are known to affect sleep maintenance, including residual effects, tolerance, and dependence. In an effort to discover new drugs that relieve insomnia symptoms while avoiding side effects, numerous studies focusing on the neurotransmitter GABA and herbal medicines have been conducted. Traditional herbal medicines, such as Piper methysticum and the seed of Zizyphus jujuba Mill var. spinosa, have been widely reported to improve sleep and other mental disorders. These herbal medicines have been applied for many years in folk medicine, and extracts of these medicines have been used to study their pharmacological actions and mechanisms. Although effective and relatively safe, natural plant products have some side effects, such as hepatotoxicity and skin reactions effects of Piper methysticum. In addition, there are insufficient evidences to certify the safety of most traditional herbal medicine. In this review, we provide an overview of the current state of knowledge regarding a variety of natural plant products that are commonly used to treat insomnia to facilitate future studies.
    [Show full text]
  • Preclinical Evaluation of Protein Disulfide Isomerase Inhibitors for the Treatment of Glioblastoma by Andrea Shergalis
    Preclinical Evaluation of Protein Disulfide Isomerase Inhibitors for the Treatment of Glioblastoma By Andrea Shergalis A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Medicinal Chemistry) in the University of Michigan 2020 Doctoral Committee: Professor Nouri Neamati, Chair Professor George A. Garcia Professor Peter J. H. Scott Professor Shaomeng Wang Andrea G. Shergalis [email protected] ORCID 0000-0002-1155-1583 © Andrea Shergalis 2020 All Rights Reserved ACKNOWLEDGEMENTS So many people have been involved in bringing this project to life and making this dissertation possible. First, I want to thank my advisor, Prof. Nouri Neamati, for his guidance, encouragement, and patience. Prof. Neamati instilled an enthusiasm in me for science and drug discovery, while allowing me the space to independently explore complex biochemical problems, and I am grateful for his kind and patient mentorship. I also thank my committee members, Profs. George Garcia, Peter Scott, and Shaomeng Wang, for their patience, guidance, and support throughout my graduate career. I am thankful to them for taking time to meet with me and have thoughtful conversations about medicinal chemistry and science in general. From the Neamati lab, I would like to thank so many. First and foremost, I have to thank Shuzo Tamara for being an incredible, kind, and patient teacher and mentor. Shuzo is one of the hardest workers I know. In addition to a strong work ethic, he taught me pretty much everything I know and laid the foundation for the article published as Chapter 3 of this dissertation. The work published in this dissertation really began with the initial identification of PDI as a target by Shili Xu, and I am grateful for his advice and guidance (from afar!).
    [Show full text]
  • Natural Chalcones in Chinese Materia Medica: Licorice
    Hindawi Evidence-Based Complementary and Alternative Medicine Volume 2020, Article ID 3821248, 14 pages https://doi.org/10.1155/2020/3821248 Review Article Natural Chalcones in Chinese Materia Medica: Licorice Danni Wang ,1 Jing Liang,2 Jing Zhang,1 Yuefei Wang ,1 and Xin Chai 1 1Tianjin State Key Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China 2School of Foreign Language, Chengdu University of Traditional Chinese Medicine, Sichuan 611137, China Correspondence should be addressed to Xin Chai; [email protected] Received 28 August 2019; Accepted 7 February 2020; Published 15 March 2020 Academic Editor: Veronique Seidel Copyright © 2020 Danni Wang et al. -is is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Licorice is an important Chinese materia medica frequently used in clinical practice, which contains more than 20 triterpenoids and 300 flavonoids. Chalcone, one of the major classes of flavonoid, has a variety of biological activities and is widely distributed in nature. To date, about 42 chalcones have been isolated and identified from licorice. -ese chalcones play a pivotal role when licorice exerts its pharmacological effects. According to the research reports, these compounds have a wide range of biological activities, containing anticancer, anti-inflammatory, antimicrobial, antioxidative, antiviral, antidiabetic, antidepressive, hep- atoprotective activities, and so on. -is review aims to summarize structures and biological activities of chalcones from licorice. We hope that this work can provide a theoretical basis for the further studies of chalcones from licorice.
    [Show full text]
  • Phytochem Referenzsubstanzen
    High pure reference substances Phytochem Hochreine Standardsubstanzen for research and quality für Forschung und management Referenzsubstanzen Qualitätssicherung Nummer Name Synonym CAS FW Formel Literatur 01.286. ABIETIC ACID Sylvic acid [514-10-3] 302.46 C20H30O2 01.030. L-ABRINE N-a-Methyl-L-tryptophan [526-31-8] 218.26 C12H14N2O2 Merck Index 11,5 01.031. (+)-ABSCISIC ACID [21293-29-8] 264.33 C15H20O4 Merck Index 11,6 01.032. (+/-)-ABSCISIC ACID ABA; Dormin [14375-45-2] 264.33 C15H20O4 Merck Index 11,6 01.002. ABSINTHIN Absinthiin, Absynthin [1362-42-1] 496,64 C30H40O6 Merck Index 12,8 01.033. ACACETIN 5,7-Dihydroxy-4'-methoxyflavone; Linarigenin [480-44-4] 284.28 C16H12O5 Merck Index 11,9 01.287. ACACETIN Apigenin-4´methylester [480-44-4] 284.28 C16H12O5 01.034. ACACETIN-7-NEOHESPERIDOSIDE Fortunellin [20633-93-6] 610.60 C28H32O14 01.035. ACACETIN-7-RUTINOSIDE Linarin [480-36-4] 592.57 C28H32O14 Merck Index 11,5376 01.036. 2-ACETAMIDO-2-DEOXY-1,3,4,6-TETRA-O- a-D-Glucosamine pentaacetate 389.37 C16H23NO10 ACETYL-a-D-GLUCOPYRANOSE 01.037. 2-ACETAMIDO-2-DEOXY-1,3,4,6-TETRA-O- b-D-Glucosamine pentaacetate [7772-79-4] 389.37 C16H23NO10 ACETYL-b-D-GLUCOPYRANOSE> 01.038. 2-ACETAMIDO-2-DEOXY-3,4,6-TRI-O-ACETYL- Acetochloro-a-D-glucosamine [3068-34-6] 365.77 C14H20ClNO8 a-D-GLUCOPYRANOSYLCHLORIDE - 1 - High pure reference substances Phytochem Hochreine Standardsubstanzen for research and quality für Forschung und management Referenzsubstanzen Qualitätssicherung Nummer Name Synonym CAS FW Formel Literatur 01.039.
    [Show full text]
  • Biotransformation of Hydroxychalcones As a Method of Obtaining Novel and Unpredictable Products Using Whole Cells of Bacteria
    catalysts Article Biotransformation of Hydroxychalcones as a Method of Obtaining Novel and Unpredictable Products Using Whole Cells of Bacteria Joanna Kozłowska 1,* , Bartłomiej Potaniec 1,2 and Mirosław Anioł 1 1 Department of Chemistry, Faculty of Biotechnology and Food Science, Wrocław University of Environmental and Life Sciences, Norwida 25, 50-375 Wrocław, Poland; [email protected] (B.P.); [email protected] (M.A.) 2 Łukasiewicz Research Network—PORT Polish Center for Technology Development, Stabłowicka 147, 54-066 Wrocław, Poland * Correspondence: [email protected] Received: 27 September 2020; Accepted: 8 October 2020; Published: 12 October 2020 Abstract: The aim of our study was the evaluation of the biotransformation capacity of hydroxychalcones—2-hydroxy-40-methylchalcone (1) and 4-hydroxy-40-methylchalcone (4) using two strains of aerobic bacteria. The microbial reduction of the α,β-unsaturated bond of 2-hydroxy-40- methylchalcone (1) in Gordonia sp. DSM 44456 and Rhodococcus sp. DSM 364 cultures resulted in isolation the 2-hydroxy-40-methyldihydrochalcone (2) as a main product with yields of up to 35%. Additionally, both bacterial strains transformed compound 1 to the second, unexpected product of reduction and simultaneous hydroxylation at C-4 position—2,4-dihydroxy-40-methyldihydrochalcone (3) (isolated yields 12.7–16.4%). During biotransformation of 4-hydroxy-40-methylchalcone (4) we observed the formation of three products: reduction of C=C bond—4-hydroxy-40-methyldihydrochalcone (5), reduction of C=C bond and carbonyl group—3-(4-hydroxyphenyl)-1-(4-methylphenyl)propan-1-ol (6) and also unpredictable 3-(4-hydroxyphenyl)-1,5-di-(4-methylphenyl)pentane-1,5-dione (7).
    [Show full text]
  • Isoliquiritigenin, an Orally Available Natural FLT3 Inhibitor from Licorice, Exhibits Selective Anti–Acute Myeloid Leukemia Efficacy in Vitro and in Vivo
    1521-0111/96/5/589–599$35.00 https://doi.org/10.1124/mol.119.116129 MOLECULAR PHARMACOLOGY Mol Pharmacol 96:589–599, November 2019 Copyright ª 2019 by The American Society for Pharmacology and Experimental Therapeutics Isoliquiritigenin, an Orally Available Natural FLT3 Inhibitor from Licorice, Exhibits Selective Anti–Acute Myeloid Leukemia Efficacy In Vitro and In Vivo Zhi-Xing Cao,1 Yi Wen,1 Jun-Lin He, Shen-Zhen Huang, Fei Gao, Chuan-Jie Guo, Qing-Qing Liu, Shu-Wen Zheng, Dao-Yin Gong, Yu-Zhi Li, Ruo-Qi Zhang, Jian-Ping Chen, and Cheng Peng Pharmacy College, Chengdu University of Traditional Chinese Medicine, Ministry of Education Key Laboratory of Standardization Downloaded from of Chinese Herbal Medicine, Key Laboratory of Systematic Research, Development and Utilization of Chinese Medicine Resources in Sichuan Province-Key Laboratory Breeding Base of Co-founded by Sichuan Province and MOST, Chengdu, China (Z.-X.C., J.-L.H., C.-J.G., S.-W.Z., D.-Y.G., Y.-Z.L., R.-Q.Z., J.-P.C., C.P.);School of Chinese Medicine, University of Hong Kong, Hong Kong, China (Y.W., F.G., Q.-Q.L., J.-P.C.); College, Shenzhen Institute of Research and Innovation, University of Hong Kong, Shenzhen, China (Y.W., F.G., Q.-Q.L., J.-P.C.); and State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China (S.-Z.H.) molpharm.aspetjournals.org Received February 19, 2019; accepted August 20, 2019 ABSTRACT Licorice is a medicinal herb widely used to treat inflammation- AML cells.
    [Show full text]
  • Influência De Chalconas Análogas, Xantonas E Monossacarídeos Na Glicemia Em Modelo Experimental Animal
    ELGA HELOISA ALBERTON INFLUÊNCIA DE CHALCONAS ANÁLOGAS, XANTONAS E MONOSSACARÍDEOS NA GLICEMIA EM MODELO EXPERIMENTAL ANIMAL FLORIANÓPOLIS 2007 Elga Heloisa Alberton INFLUÊNCIA DE CHALCONAS ANÁLOGAS, XANTONAS E MONOSSACARÍDEOS NA GLICEMIA EM MODELO EXPERIMENTAL ANIMAL Dissertação apresentada ao curso de Pós-graduação em Farmácia da Universidade Federal de Santa Catarina, como requisito parcial para o título de Mestre em Farmácia. Área de concentração: Análises Clínicas . Orientadora: Profa. Dra. Fátima Regina Mena Barreto Silva Florianópolis 2007 ALBERTON, Elga Heloisa Influência de chalconas análogas, xantonas e monossacarídeos na glicemia em modelo experimental animal/Elga Heloisa Alberton. Flrianópolis, 2006. //p. Dissertação (Mestrado) – Universidade Federal de Santa Catarina. Programa de pós Graduação em Farmácia 1. Diabetes. 2. Ácido glicônico. 3. Ácido tatárico. 4. Polygala paniculata. 5. Polygala cyparissias. 6. Xantonas. 7. Chalconas. “INFLUÊNCIA DE CHALCONAS ANÁLOGAS, XANTONAS E MONOSSACARÍDEOS NA GLICEMIA EM MODELO EXPERIMENTAL ANIMAL” POR ELGA HELOISA ALBERTON Dissertação julgada e aprovada em sua forma final pelo Orientador e membros da Banca Examinadora, composta pelos Professores Doutores: Banca Examinadora: ____________________________________ Adair Roberto Soares dos Santos (UFSC) ____________________________________ Danilo Wilhelm Filho (UFSC) ____________________________________ Maria Rosa Chitolina Schetinger (UFSM-RS) Florianópolis, 12 de fevereiro de 2007. Dedico este trabalho aos meus pais, Hercílio C. Alberton e Alba R. Lopes Minatto, pela oportunidade recebida e, que por vezes tão longe fisicamente, estiveram sempre, através de seu carinho e apoio, presentes em todos os momentos da minha vida. AGRADECIMETOS A DEUS por me conceder a oportunidade de realizar mais um sonho. Agradecimento especial à minha orientadora Profa. Dra. Fátima Regina Mena Barreto Silva, pela confiança em mim depositada.
    [Show full text]
  • Piper Methysticum)
    Journal of Student Research (2015) Volume 4, Issue 2: pp. 69-72 Research Article A Closer Look at the Risks vs. Benefits of Kava (Piper methysticum) Anan A. Husseina If you took a trip to Fiji, the locals would probably welcome you with a drink of Kava. For centuries, the indigenous people of the South Pacific Islands have used the roots of a plant known as Kava. Beyond the use of Kava as a psychoactive substance, it has been incorporated as a cultural drink that is used in many ceremonies. In the late 1990’s Kava use spread quickly in Western countries including Europe, North America, and Australia. It was used as a treatment for anxiety. But just as quickly as it spread, the enthusiasm for it faded, because it was banned or restricted in many Western countries following reports of liver toxicity. In the United States, the Food and Drug Administration’s (FDA) concern for safety prompted a request for more research on the substance. The issues of safety and efficacy remain more specifically whether the benefits of using Kava outweigh the risks. History Kava is a beverage made from the roots of the plant included alcohol, cocaine, tobacco, and heroin. The findings Piper methysticum, and has been used historically in the suggest that kava may reduce the craving associated with the South Pacific Islands as a ceremonial drink. Kava was aforementioned substances, which may make kava a great introduced in Europe around the 1700s by Captain James future candidate to help with addiction. 13 Cook and has since spread widely to Australia, Europe, and Although the mechanism of action is not clear, it is the United States.
    [Show full text]
  • WO 2017/131957 Al 3 August 2017 (03.08.2017) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2017/131957 Al 3 August 2017 (03.08.2017) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 8/35 (2006.01) A61Q 5/00 (2006.01) kind of national protection available): AE, AG, AL, AM, A61K 8/97 (2006.01) AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, (21) International Application Number: DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, PCT/US2017/012985 HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, (22) International Filing Date: KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, 11 January 2017 ( 11.01 .2017) MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, (25) Filing Language: English RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, (26) Publication Language: English TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: 62/287,501 27 January 2016 (27.01.2016) US (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, (71) Applicant: ELC MANAGEMENT LLC [US/US]; 155 GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, Pinelawn Road, Suite 345 South, Melville, New York TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, 11747 (US).
    [Show full text]
  • From Alpinia Zerumbet: Its Isolation, Synthesis, and Characterization
    Molecules 2015, 20, 16306-16319; doi:10.3390/molecules200916306 OPEN ACCESS molecules ISSN 1420-3049 www.mdpi.com/journal/molecules Review Dihydro-5,6-dehydrokavain (DDK) from Alpinia zerumbet: Its Isolation, Synthesis, and Characterization Tran Dang Xuan 1 and Rolf Teschke 2,* 1 Division of Development Technology, Graduate School for International Development and Cooperation (IDEC), Hiroshima University, Higashi Hiroshima 739-8529, Japan; E-Mail: [email protected] 2 Department of Internal Medicine II, Division of Gastroenterology and Hepatology, Klinikum Hanau, Academic Teaching Hospital of the Medical Faculty of the Goethe University, Frankfurt/Main, 63450 Hanau, Germany * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +49-6181-218-59; Fax: +49-6181-296-4211. Academic Editor: Derek J. McPhee Received: 9 June 2015 / Accepted: 20 August 2015 / Published: 9 September 2015 Abstract: Dihydro-5,6-dehydrokavain (DDK) is the major and most promising component of the tropical plant Alpinia zerumbet (shell ginger), a species of the ginger family Zingiberaceae. Alpinia zerumbet is known for its human use as a traditional herbal medicine, food, and dietary supplement. With its α-lactone ring, DDK belongs to the large chemical group of kavalactones, which are also found in kava (Piper methysticum), another herbal medicine; DDK is characterized by a double-bond linkage at positions 5,6 and the absence of a double-bond linkage at positions 7,8. This dissociates DDK from other kavalactones with their linkages at positions 7,8 and 5,6 that are both either completely saturated or unsaturated, or may have an unsaturated bond at the position 7,8 as well as a saturated bond at the position 5,6.
    [Show full text]
  • The Biosynthetic Origin of Psychoactive Kavalactones in Kava
    bioRxiv preprint doi: https://doi.org/10.1101/294439; this version posted April 4, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. The biosynthetic origin of psychoactive kavalactones in kava 1 1 1,2 1,2 Tomáš Pluskal ,​ Michael P. Torrens-Spence ,​ Timothy R. Fallon ,​ Andrea De Abreu ,​ ​ ​ ​ ​ 1,2 1,2, Cindy H. Shi ,​ and Jing-Ke Weng *​ ​ ​ 1 Whitehead​ Institute for Biomedical Research, 455 Main Street, Cambridge, MA 02142 USA. 2 Department​ of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139 USA. *Corresponding author. Email: [email protected] ​ 1 bioRxiv preprint doi: https://doi.org/10.1101/294439; this version posted April 4, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract For millennia, humans have used plants for medicinal purposes. However, our limited understanding of plant biochemistry hinders the translation of such ancient wisdom into modern 1 pharmaceuticals .​ Kava (Piper methysticum) is a medicinal plant native to the Polynesian islands ​ ​ ​ with anxiolytic and analgesic properties supported by over 3,000 years of traditional use as well 2–5 as numerous recent clinical trials .​ The main psychoactive principles of kava, kavalactones, are ​ a unique class of polyketide natural products known to interact with central nervous system through mechanisms distinct from those of the prescription psychiatric drugs benzodiazepines 6,7 and opioids .​ Here we report de novo elucidation of the biosynthetic pathway of kavalactones, ​ ​ ​ consisting of seven specialized metabolic enzymes.
    [Show full text]